Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) EBT Margin (2016 - 2025)

Wave Life Sciences (WVE) has disclosed EBT Margin for 11 consecutive years, with 580.17% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, EBT Margin fell 41298.0% year-over-year to 580.17%, compared with a TTM value of 1143.44% through Dec 2025, down 84245.0%, and an annual FY2025 reading of 478.33%, down 38876.0% over the prior year.
  • EBT Margin was 580.17% for Q2 2025 at Wave Life Sciences, down from 510.93% in the prior quarter.
  • Across five years, EBT Margin topped out at 13.36% in Q3 2023 and bottomed at 13685.61% in Q3 2022.
  • Average EBT Margin over 5 years is 2372.5%, with a median of 510.93% recorded in 2025.
  • The sharpest move saw EBT Margin crashed -1366851bps in 2022, then soared 1369897bps in 2023.
  • Year by year, EBT Margin stood at 1982.38% in 2021, then crashed by -75bps to 3472.8% in 2022, then soared by 98bps to 55.95% in 2023, then plummeted by -199bps to 167.19% in 2024, then plummeted by -247bps to 580.17% in 2025.
  • Business Quant data shows EBT Margin for WVE at 580.17% in Q2 2025, 510.93% in Q1 2025, and 167.19% in Q2 2024.